ArticleJournal of fungi (Basel, Switzerland)2020
Biosynthesis of Silver Nanoparticles Using Onion Endophytic Bacterium and Its Antifungal Activity against Rice Pathogen
Article in Journal of fungi (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Bioactive Silver Nanoparticles Synthesized Using EndophyticPharmaceuticals (Basel, Switzerland) · 2026Article
- Harnessing an endophytic Bacillus strain closely related to Bacillus velezensis for biocontrol of twig blight in bayberry caused by Pestalotiopsis versicolor.BMC plant biology · 2026Article
- Ultrastructural changes and defense strategy of yellow lupine during silver nanoparticle and Fusarium oxysporum interaction.Scientific reports · 2026Article
- Histone Demethylase MoRph1 Regulates Fungal Development, Pathogenicity, and DNA Damage Repair inJournal of fungi (Basel, Switzerland) · 2026Article
- Green synthesis of silver nanoparticles using fermentation extracts from a mangrove soil bacterium: morphological characterization, and antifungal activities against rice blast fungus.Pest management science · 2026Article
- Silver nanoparticles synthesised using endophytic fungus Calonectria eucalypti from medicinal plant axifraga stolonifera and their bioactivity.Journal, genetic engineering & biotechnology · 2025Article
- Multifunctional Roles and Ecological Implications of Nano-Enabled Technologies inPlants (Basel, Switzerland) · 2025Review
- Suppression of Root Rot Fungal Diseases in Common Beans (Nanomaterials (Basel, Switzerland) · 2024Article
- Review
- Biocontrol Efficacy of EndophytePlants (Basel, Switzerland) · 2023Article
- Synthesis and characterization of NiScientific reports · 2022Article
- γ-Polyglutamic Acid Production, Biocontrol, and Stress Tolerance: Multifunction ofInternational journal of environmental research and public health · 2022Article
- Article
- Toxicity and action mechanisms of silver nanoparticles against the mycotoxin-producing fungusJournal of advanced research · 2022Article
- Endophytic Microbiota of Rice and Their Collective Impact on Host Fitness.Current microbiology · 2022Review
- Characterization and Antimicrobial Activity of Silver Nanoparticles Synthesized with the Peel Extract of Mango.Materials (Basel, Switzerland) · 2021Article
- Special Issue: Fungal Nanotechnology.Journal of fungi (Basel, Switzerland) · 2021Article
- Bactericidal and Virucidal Activities of Biogenic Metal-Based Nanoparticles: Advances and Perspectives.Antibiotics (Basel, Switzerland) · 2021Review
- Recent Advances in Bioactive Compounds, Health Functions, and Safety Concerns of Onion (Frontiers in nutrition · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Biosynthesis of silver nanoparticles (AgNPs) using endophytic bacteria is a safe alternative to the traditional chemical method. The purpose of this research is to biosynthesize AgNPs using endophytic bacterium
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.